Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus magnesium sulfate for bleeding control in septorhinoplasty
IRCT20170413033408N4Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial comparing Clonidine with Magnesium sulfate (2 arms). Primary endpoint: Bleeding volume. Started Aug 2020; status: completed.
02
Drugs
clonidinemagnesium sulfate
Beyond the preview
Go deeper on IRCT20170413033408N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170413033408N4.